Circ re.Issue of Options

Circ re.Issue of Options

Eco Animal Health Group Plc

Issue of Share Options

ECO Animal Health Group plc

(“ECO” or the “Company”)

14 October 2013

The Company announces that on 9^th October 2013, subject to shareholder approval at the forthcoming General Meeting to be held on the 22^nd October 2013 in respect of the issue of 7,053,385 new ordinary shares of 5p further to our announcement on the 3^rd October 2013 “Issue of Equity”, the Board has granted new options to certain Directors of the Company under the Company’s executive share option scheme. The options will vest on 9^th October 2016 and have been granted as follows:

Director	Â	Number of options granted	Â	Exercise price
Marc Loomes		150,000		£1.96
Brett Clemo		100,000		£1.96
Julia Trouse		50,000		£1.96
Kevin Stockdale		50,000		£1.96

As previously disclosed on the 3^rd October 2013 following the General Meeting, certain directors of the Company have exercised options over ordinary shares in the company at a price of between 109p and 161p, and will sell these shares at the Placing Price. Peter Lawrence will acquire 105,263 of these new ordinary shares at the Placing Price. His total holding in the Company following this acquisition will be 18.22%.

As announced previously, the Directors’ shareholdings following the exercise and sale are set out below.

Name	Â	No of options being exercised and ordinary share immediately sold	Â	Exercise price for options (p)	Â	Sale price of new shares (p)	Â	Holding after exercise and sale	Â	Percentage holding after exercise and sale of new shares*
Brett Clemo		175,000		40,000 -147 35,000 – 135 75,000 – 150 25,000 – 161		190		436,948		0.70%
Marc Loomes		233,370		100,000- 147 120,000-150 13,370-109		190		1,131,110		1.81%
Kevin Stockdale		145,000		70,000 – 147 75,000 - 150		190		350,411		0.56%
Julia Trouse		145,000		70,000 – 147 75,000 - 150		190		518,605		0.83%

Following the issue of the new ordinary shares the Company’s total issued share capital with voting rights and which is admitted to trading on AIM will consist of 62,429,321 ordinary shares of 5p each, with one voting right per share.

Enquiries

ECO Animal Health Group plc	Â
Peter Lawrence, Executive Chairman		020 8336 6190
Marc Loomes, CEO		020 8447 8899
Â
Spiro Financial
Anthony Spiro		020 8336 6196
Â
Â
Cenkos Securities plc (Nominated Adviser)
Stephen Keys		020 7397 8926
Elizabeth Bowman		020 7397 8928

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.